Ines Glojnarić

1.0k total citations
32 papers, 779 citations indexed

About

Ines Glojnarić is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ines Glojnarić has authored 32 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Ines Glojnarić's work include Immune Response and Inflammation (7 papers), Asthma and respiratory diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Ines Glojnarić is often cited by papers focused on Immune Response and Inflammation (7 papers), Asthma and respiratory diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Ines Glojnarić collaborates with scholars based in Croatia, Austria and United Kingdom. Ines Glojnarić's co-authors include Vesna Eraković Haber, Snježana Čužić, Martina Bosnar, Karmen Brajša, Ognjen Čulić, Michael J. Parnham, Berislav Bošnjak, Ivana Čepelak, Željko Ferenčić and Vesna Munić Kos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Ines Glojnarić

32 papers receiving 746 citations

Peers

Ines Glojnarić
Brian S. Murphy United States
Mark J. Cowan United States
Franklin R. McGuire United States
Ulrich Grandel Germany
Zhijun Jie China
Franziska M. Konrad Germany
Zhenhua Wang China
Daishun Liu China
Shanjana Awasthi United States
Snježana Čužić Croatia
Brian S. Murphy United States
Ines Glojnarić
Citations per year, relative to Ines Glojnarić Ines Glojnarić (= 1×) peers Brian S. Murphy

Countries citing papers authored by Ines Glojnarić

Since Specialization
Citations

This map shows the geographic impact of Ines Glojnarić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Glojnarić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Glojnarić more than expected).

Fields of papers citing papers by Ines Glojnarić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ines Glojnarić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Glojnarić. The network helps show where Ines Glojnarić may publish in the future.

Co-authorship network of co-authors of Ines Glojnarić

This figure shows the co-authorship network connecting the top 25 collaborators of Ines Glojnarić. A scholar is included among the top collaborators of Ines Glojnarić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ines Glojnarić. Ines Glojnarić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kragol, Goran, Victoria A. Steadman, Martina Bosnar, et al.. (2022). Unprecedented Epimerization of an Azithromycin Analogue: Synthesis, Structure and Biological Activity of 2′-Dehydroxy-5″-Epi-Azithromycin. Molecules. 27(3). 1034–1034. 1 indexed citations
2.
Hrvačić, Boška, et al.. (2022). Retrospektivna procjena učinka nintedaniba u mišjem modelu plućne fibroze. Veterinarska stanica. 54(4). 395–406. 1 indexed citations
3.
Banjanac, Mihailo, et al.. (2019). Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 55. 75–83. 27 indexed citations
4.
Stulik, Lukas, Harald Rouha, Zehra Visram, et al.. (2019). Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid. Scientific Reports. 9(1). 5339–5339. 22 indexed citations
5.
6.
Hrvačić, Boška, et al.. (2014). Relative potencies of three glucocorticoids to induce hypoplasia of the physis and concomitant biochemical alterations in the rat. Drug and Chemical Toxicology. 38(3). 272–277. 1 indexed citations
7.
Glojnarić, Ines, Snježana Čužić, & Darko Marković. (2013). Evaluation of hydroxypropyl-beta-cyclodextrin (HPβCD) as formulation vehicle for use in general toxicity studies in mice. Toxicology Letters. 221. S93–S93. 1 indexed citations
8.
Jelić, Dubravko, Boška Hrvačić, Karmen Brajša, et al.. (2012). Porphyrins as new endogenous anti-inflammatory agents. European Journal of Pharmacology. 691(1-3). 251–260. 15 indexed citations
9.
Hrvačić, Boška, Martina Bosnar, Snježana Čužić, et al.. (2012). Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories. Translational research. 160(2). 137–145. 10 indexed citations
10.
Kos, Vesna Munić, Jovica Ralić, Barbara Stanić, et al.. (2012). Macrolactonolides: A novel class of anti-inflammatory compounds. Bioorganic & Medicinal Chemistry. 21(1). 321–332. 11 indexed citations
11.
Čužić, Snježana, Martina Bosnar, Željko Ferenčić, et al.. (2012). Claudin-3 and Clara Cell 10 kDa Protein as Early Signals of Cigarette Smoke–Induced Epithelial Injury along Alveolar Ducts. Toxicologic Pathology. 40(8). 1169–1187. 18 indexed citations
12.
Bošnjak, Berislav, Snježana Čužić, Željko Ferenčić, et al.. (2009). Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma. Inflammation Research. 58(11). 773–781. 4 indexed citations
13.
Hrvačić, Boška, Berislav Bošnjak, Martina Bosnar, et al.. (2009). Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma. European Journal of Pharmacology. 616(1-3). 236–243. 20 indexed citations
14.
Bosnar, Martina, Berislav Bošnjak, Snježana Čužić, et al.. (2009). Azithromycin and Clarithromycin Inhibit Lipopolysaccharide-Induced Murine Pulmonary Neutrophilia Mainly through Effects on Macrophage-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-1β. Journal of Pharmacology and Experimental Therapeutics. 331(1). 104–113. 72 indexed citations
15.
Glojnarić, Ines, Snježana Čužić, Vesna Eraković Haber, & Michael J. Parnham. (2007). The serum amyloid A response to sterile silver nitrate in mice and its inhibition by dexamethasone and macrolide antibiotics. International Immunopharmacology. 7(12). 1544–1551. 6 indexed citations
16.
Čužić, Snježana, et al.. (2006). Accelerated Healing of Excisional Skin Wounds by PL 14736 in Alloxan-Hyperglycemic Rats<sup>1</sup>. Skin Pharmacology and Physiology. 19(5). 266–274. 21 indexed citations
17.
Dodig, Slavica, et al.. (2005). Thrombopoietin and Interleukin-6 in Children with Pneumonia-Associated Thrombocytosis. Archives of Medical Research. 36(2). 124–128. 18 indexed citations
18.
Parnham, Michael J., Ognjen Čulić, Vesna Eraković Haber, et al.. (2005). Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. European Journal of Pharmacology. 517(1-2). 132–143. 79 indexed citations
19.
Čulić, Ognjen, Vesna Eraković Haber, Ivana Čepelak, et al.. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. European Journal of Pharmacology. 450(3). 277–289. 181 indexed citations
20.
Brajša, Karmen, et al.. (2000). Erythromycin inhibits LPS induced inflammation in rats. 94–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian S. Murphy Breakdown of academic impact, for papers by Mark J. Cowan Breakdown of academic impact, for papers by Franklin R. McGuire Breakdown of academic impact, for papers by Ulrich Grandel Breakdown of academic impact, for papers by Zhijun Jie Breakdown of academic impact, for papers by Franziska M. Konrad Breakdown of academic impact, for papers by Zhenhua Wang Breakdown of academic impact, for papers by Daishun Liu Breakdown of academic impact, for papers by Shanjana Awasthi Breakdown of academic impact, for papers by Snježana Čužić
Rankless by CCL
2026